Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0315643 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ambika Ramesh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America. Hauptthemen laut MEDLINE: Acute Kidney Injury, Vasoconstrictor Agents, Hospital Mortality, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Objective
To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT).
Methods
Patients with AKI who underwent CKRT between 1/1/2012-1/1/2021 at a tertiary academic hospital were included. Cox proportional hazard model was used to assess the relationship between time-dependent vasopressor dose and in-hospital mortality.
Results
There were 641 patients with AKI that required CKRT. In-hospital mortality occurred in 318 (49.6%) patients. Those who died were older (63 vs 57 years), had higher SOFA score (10.6 vs 9) and lactate (6 vs 3.3 mmol/L). In multivariable model, increasing doses of norepinephrine [HR 4.4 (95% CI: 2.3–7, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America.
- Department of Pharmaceutical Systems and Policy, West Virginia University, Morgantown, West Virginia, United States of America.
- Division of Data-Driven and Digital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
- Division of Nephrology, Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America.
ORCID-Profile: Khaled Shawwa
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Ramesh, A., Doddi, A., Abbasi, A., Al-Mamun, M. A., Sakhuja, A., & Shawwa, K. (2024). Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0315643
Vancouver
Ramesh A, Doddi A, Abbasi A, Al-Mamun MA, Sakhuja A, Shawwa K. Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. PLOS ONE. 2024. doi:10.1371/journal.pone.0315643
BibTeX
@article{Ramesh2024,
author = {Ramesh, Ambika and Doddi, Akshith and Abbasi, Aisha and Al-Mamun, Mohammad A and Sakhuja, Ankit and Shawwa, Khaled},
title = {Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0315643}
}
EUVIMED